Skip to main content

page search

Library Biotech--Who Wins? Economic Benefits and Costs of Biotechnology Innovations in Agriculture

Biotech--Who Wins? Economic Benefits and Costs of Biotechnology Innovations in Agriculture

Biotech--Who Wins? Economic Benefits and Costs of Biotechnology Innovations in Agriculture

Resource information

Date of publication
December 2001
Resource Language
ISBN / Resource ID
AGRIS:US2016202321

The conceptual model necessary for an assessment of biotechnology's economic benefits and costs is outlined, emphasizing the need to account for the proprietary nature of biotechnology innovations. The model is illustrated with an application to Roundup Ready soybeans. The estimated value of this innovation is sizeable, with consumers and innovators claiming the largest shares of net benefits. Also, disparities in intellectual property rights protection across countries affect the distribution of benefits. Consumer resistance toward GMOs and the issue of labelling and market segregation complicate the economic evaluation of biotechnology innovations; a number of related regulation and public policy issues are discussed. Emerging output-trait GMOs are potentially less controversial than some earlier GMOs and may bring more benefits to all participants in the agri-food sector, but this outcome depends crucially on the development of an effective, credible, and internationally harmonized regulatory system.

Share on RLBI navigator
NO

Authors and Publishers

Author(s), editor(s), contributor(s)

Moschini, GianCarlo

Publisher(s)
Data Provider